Evrofarma SA (ATH:EVROF)
3.940
-0.020 (-0.51%)
Sep 11, 2026, 5:17 PM EET
| Market Cap | 53.86M +51.5% |
| Revenue (ttm) | 49.44M +8.1% |
| Net Income | 3.53M +54.6% |
| EPS | 0.26 +54.7% |
| Shares Out | 13.67M |
| PE Ratio | 15.28 |
| Forward PE | n/a |
| Dividend | 0.06 (1.47%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 1,579 |
| Open | 3.970 |
| Previous Close | 3.960 |
| Day's Range | 3.880 - 3.970 |
| 52-Week Range | 2.380 - 4.370 |
| Beta | 0.71 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 25, 2026 |